CogCoach-Health: A Groundbreaking Trial for Early Intervention

A new randomized controlled trial launched in late 2025 is making waves in Australian dementia research. Known as CogCoach-Health, this 12-month study led by Professor Kaarin Anstey at the University of New South Wales (UNSW) and Neuroscience Research Australia (NeuRA) specifically targets adults aged 65 and older experiencing subjective cognitive decline (SCD) or mild cognitive impairment (MCI). These individuals often notice persistent memory concerns but lack a formal dementia diagnosis, placing them at higher risk of progression.

The trial's core aim is to demonstrate that targeted lifestyle interventions can reduce dementia risk factors, improve cognitive function, and potentially halt cognitive decline before it escalates. With recruitment ongoing across all Australian states, it seeks 634 participants, of whom 21 have enrolled so far. This initiative builds on Australia's growing emphasis on prevention, as dementia affects an estimated 446,500 people in 2026, making it the leading cause of death.

The Dementia Crisis in Australia: Scale and Urgency

Dementia prevalence is surging due to an ageing population, with projections estimating over one million cases by 2058. Currently, one in five older Australians experiences mild memory loss, a transitional stage to more severe cognitive issues. Leading causes include Alzheimer's disease, vascular dementia, and other neurodegenerative conditions. Modifiable risk factors, as outlined by the Lancet Commission, account for up to 45% of cases globally, including physical inactivity, poor diet, smoking, depression, and social isolation—many of which CogCoach-Health addresses.

Australian research highlights that addressing these early could prevent or delay 38-41% of cases locally. Tools like the Australian National University-Alzheimer's Disease Risk Index (ANU-ADRI) quantify exposure to these factors, serving as the trial's primary outcome measure.

Professor Kaarin Anstey: A Pioneer in Dementia Prevention

Scientia Professor Kaarin Anstey, Director of UNSW's Ageing Futures Institute and Senior Principal Scientist at NeuRA, has dedicated over 20 years to cognitive ageing and dementia risk reduction. She chairs the International Research Network on Dementia Prevention and serves on the World Dementia Council. Anstey developed the CogDrisk tool, a free online assessment evaluating 12 modifiable risk factors based on WHO guidelines, providing personalized reports for prevention.

Her work emphasizes scalable digital interventions, positioning universities like UNSW as hubs for translational neuroscience. For aspiring researchers, opportunities abound in higher ed research jobs focusing on brain health.

Subjective Cognitive Decline and Mild Cognitive Impairment Explained

Subjective Cognitive Decline (SCD) involves self-reported memory worries persisting for months, often preceding objective MCI, where tests show mild deficits but daily function remains intact. About 20% of those over 65 experience SCD, with 10-15% progressing to dementia annually if unaddressed. CogCoach-Health uses the Everyday Cognition (ECog-12) scale (score ≥1.54) or MCI criteria for inclusion, excluding moderate/severe impairment.

These stages offer a critical window for intervention, as early detection via self-report often precedes clinical findings. Participants must have at least one risk factor (e.g., low activity, poor diet) per CogDrisk.

The CogCoach-Health Intervention: A Multi-Domain Approach

The intervention arm features a 12-week e-learning program with six modules: healthy brain ageing, memory strategies, physical activity, diet (MIND diet emphasizing plants, healthy fats), cognitive/social engagement, and stress reduction. Each 30-40 minute module includes interactive activities, goal-setting, and reflections.

• Telehealth cognitive session (psych RA): BrainHQ subscription for executive/memory training (2 hours/week).
• Two exercise physiology sessions: Personalized plans meeting Australian guidelines, apps like PhysiTrack.
• Two dietitian sessions: MIND diet adaptations.
• Two booster sessions at 4/9 months.

Control receives general emails. All online, accessible nationwide.Learn more and express interest.

Photo by Manny Becerra on Unsplash

Outcomes and Evaluation: ANU-ADRI at the Core

Primary: ANU-ADRI reduction at 12 months, assessing 11 factors like age, education, hypertension. Secondary: Cognition (mNTB), activity (step count), MIND diet adherence, engagement, quality of life, literacy. Blinded assessors ensure rigor; power for 3-point ANU-ADRI drop or 0.25 SD cognition gain.

Funded by MRFF Dementia Mission, it could inform GP-recommended programs. Contact: cogcoach.health@unsw.edu.au or 02 9348 3111.

Building on Maintain Your Brain: Proven Digital Success

CogCoach-Health follows MYB, a 3-year UNSW-led trial (6,000+ participants) published in Nature Medicine (Jan 2025). Personalized online modules (exercise, diet, brain training, mental health) yielded superior cognition scores vs. control, especially for 55-65s. MYB proves scalability; CogCoach targets higher-risk SCD/MCI groups.MYB publication.

Both underscore university-led digital tools' role in prevention.

Lancet Commission's 14 Modifiable Risk Factors

The 2024 Lancet update identifies 14 factors (e.g., hearing loss, vision impairment, high cholesterol, TBI) preventing 45% of dementias. Australian adaptations via ANU-ADRI/CogDrisk prioritize local relevance. CogCoach tackles physical inactivity (8% attributable), poor diet (2%), low engagement (4%).

• Early-life: Low education, hearing loss.
• Mid-life: Hypertension, obesity, depression, TBI.
• Late-life: Smoking, inactivity, isolation, pollution.

Trials like CogCoach provide actionable evidence.

Implications for GPs, Policy, and Public Health

GPs often see patients with memory worries but lack options; CogCoach offers evidence-based support, fostering proactive discussions. Scalable online delivery suits Australia's vast geography. Success could integrate into primary care, reducing burden (projected $20B+ annual cost by 2050).

Explore research assistant roles advancing such trials.

Career Opportunities in Australian Dementia Research

Universities drive innovation: UNSW/NeuRA seek postdocs in psychology/epidemiology. Roles span neuroscience, public health, digital health. Demand grows with funding like MRFF. Check Australian university jobs in research.

Photo by Bruno Aguirre on Unsplash

Future Outlook: Towards a Dementia-Resilient Australia

CogCoach-Health, ending recruitment 2026, could validate multi-domain prevention for at-risk groups, complementing MYB. Combined with tools like CogDrisk, it empowers individuals. National campaigns urged for brain health investment.

Interested? Contribute via trial registry. For careers, visit higher ed jobs, rate my professor, university jobs, higher ed career advice.